BSX Stock: Is It Time To Buy Or Sell Puts?
Yahoo · 9 de sept de 2026
Trading near $45 a share, Boston Scientific (BSX) sits roughly 58% below its 52-week peak. Instead of buying the dip outright, selling cash-secured put options…
CEDEAR ABT
Abbott Labs
Sí, existe CEDEAR de ABT en Argentina. Operás bajo el ticker ABT en BYMA, con ratio 4:1 respecto a la acción en NYSE.
Empresa subyacente
HealthcareMedical Devices
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
- País
- United States
- Empleados
- 122.000
- Sitio web
- abbott.com
Precio histórico
Últimos 200 días · 12/11/25 — 09/09/26
-12.64%
Cotización y datos
NYSERatio 4:1 · Subyacente ABT
CEDEAR (ARS)
Precio
$ 41.380
Var. %
-1,33%
Volumen operado
402
Subyacente (USD)
Precio ABT
US$ 104,00
Teórico (precio / ratio)
ABT ÷ 4
US$ 26,00
Dólar MEP (ABTD)
Preguntas frecuentes
¿Existe CEDEAR de ABT en Argentina?
Sí, existe el CEDEAR de ABT (Abbott Labs) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es ABT.
¿Cuál es el ticker del CEDEAR de Abbott Labs?
El ticker del CEDEAR de Abbott Labs en Argentina es ABT. La acción subyacente cotiza en NYSE con el símbolo ABT.
¿Cuál es el ratio del CEDEAR ABT?
El CEDEAR ABT tiene un ratio de 4:1. Eso significa que 4 CEDEARs equivalen a 1 acción de ABT.
¿Cuánto vale el CEDEAR ABT hoy?
El CEDEAR ABT cotiza hoy a $ 41.380 en pesos argentinos, con una variación diaria de -1,33%.
¿Cuánto vale la acción ABT en dólares?
La acción subyacente ABT (Abbott Labs) cotiza a US$ 104,00 en su mercado de origen (NYSE).
Noticias
NVST or ABT: Which Is the Better Value Stock Right Now?
Yahoo · 9 de sept de 2026
NVST vs. ABT: Which Stock Is the Better Value Option?
Abbott Receives FDA Nod for TactiFlex Duo: Stock to Gain?
Yahoo · 9 de sept de 2026
FDA approval for TactiFlex Duo expands ABT's AFib ablation portfolio with dual PFA and RF energy options, supporting broader U.S. adoption.